Unlike ACE2, which is mainly linked to direct viral entry, DPPIV is deeply involved in regulating glucose metabolism, immune responses, and chronic inflammation, all of which are key in the progression of post-COVID-19 fatigue and cerebrovascular complications [72]. The gene discussed is ACE2; the disease is COVID-19.